Injective (INJ) is currently priced at $3.02, exhibiting a 24-hour change of 2.76%. The daily trading range shows slight volatility with a low of $2.90 and a high reaching the current price, indicating a tight market condition.

Volume stands at approximately 41.59 million, corresponding to a volume-to-market cap ratio of 13.78%, which suggests healthy trading activity relative to its market capitalization. The hourly moving averages indicate a positive trend, with the 8 SMA at $2.97 reflecting a 1.66% increase and higher SMAs showing progressively stronger gains, signaling bullish momentum.

The 1-hour Relative Strength Index (RSI) is at 68, suggesting that INJ is approaching overbought territory, which could limit further short-term upside. In contrast, the 7-day RSI at 50 indicates a neutral stance, reflecting a lack of significant buying or selling pressure over the past week.

Short-term price changes exhibit a downward trend, with a 7-day drop of approximately 4.19%, a 14-day decline of about 9.99%, and a 30-day decrease of roughly 4.63%. This suggests that despite the recent uptick, the overall trend remains bearish in the longer term, indicating a potential correction phase is still in play.

The all-time high for INJ was $52.62, achieved on March 14, 2024, highlighting significant room for growth relative to its current price. However, the recent performance and lack of upward momentum in the medium-term price changes raise concerns about sustainability in the rally.

Given the mixed signals from technical indicators, with short-term bullish trends contrasted by longer-term bearish patterns, the recommendation is to Hold. This strategy allows investors to monitor the situation closely while waiting for clearer signs of a reversal or sustained momentum.